Cost per DALY averted in low, middle- and high-income countries: evidence from the global burden of disease study to estimate the cost-effectiveness thresholds

Cost per DALY averted in low, middle- and high-income countries: evidence from the global burden of disease study to estimate the cost-effectiveness thresholds

Abstract Background Determining the cost-effectiveness thresholds for healthcare interventions has been a severe challenge for policymakers, especially in low- and middle-income countries. This study aimed to estimate the cost per disability-adjusted life-year (DALY) averted for countries with diffe...

Full description

Bibliographic Details
Main Authors: Rajabali Daroudi, Ali Akbari Sari, Azin Nahvijou, Ahmad Faramarzi
Format: Article
Language:English
Published: BMC 2021-02-01
Series:Cost Effectiveness and Resource Allocation
Subjects:
DALY
HDI
GDP per capita
Health expenditure
Online Access:https://doi.org/10.1186/s12962-021-00260-0

Internet

https://doi.org/10.1186/s12962-021-00260-0

Similar Items